Suppr超能文献

更严重的合并症、高龄和未完成疫苗接种会增加新冠病毒感染相关死亡风险。

More severe comorbidities, advanced age, and incomplete vaccination increase the risk of COVID-19 mortality.

作者信息

Pradhevi Lukita, Soegiarto Gatot, Wulandari Laksmi, Lusida Michael Ap, Saefudin Rendra P, Vincent Agustinus

机构信息

Department of Internal Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.

Department of Internal Medicine, Dr. Soetomo General Academic Hospital, Surabaya, Indonesia.

出版信息

Narra J. 2024 Aug;4(2):e949. doi: 10.52225/narra.v4i2.949. Epub 2024 Aug 14.

Abstract

Numerous studies have stated that comorbidities are risk factors for coronavirus disease 2019 (COVID-19) mortality, but few have considered the severity or stage of these comorbidities. The aim of this study was to determine the association between the severity of comorbidity, age, and number of COVID-19 vaccinations with COVID-19 mortality. This case-control study was conducted from July 2021 until December 2022 at the Dr. Soetomo General Academic Hospital, Surabaya, Indonesia. The patients were divided into non-survived patients (case group) and survived patients (control group). The inclusion criteria for cases were adult patients hospitalized with confirmed COVID-19, based on reverse transcriptase-polymerase chain reaction (RT-PCR) testing of nasopharyngeal swabs. Using total sampling, 1,046 confirmed COVID-19 patients, which consisted of 450 (43%) non-survived patients and 596 (57%) survived patients, were included. The most common comorbidity was diabetes mellitus (DM) (82.7%), chronic kidney disease (CKD) (43%), hypertension (25.7%), and obesity (23.6%). Our multivariate analysis indicated that older age (aOR: 1.03; 95%CI: 1.02-1.04, <0.001), male sex (aOR: 1.29; 95%CI: 1.11- 2.00, =0.007), severe COVID-19 at first admission (aOR: 3.13; 95%CI: 2.08-4.73, <0.001), having pneumonia (aOR: 1.99; 95%CI: 1.21-3.33, =0.005), poorly controlled DM with HbA1c≥9% (aOR: 2.90; 95%CI: 1.72-4.89, <0.001), severe obesity with body mass index (BMI)≥30 (OR: 2.90; 95%CI: 1.72-4.89, <0.001), hypertension stage 2 (aOR: 1.99; 95%CI: 1.12-3.53, =0.019) or stage 3 (aOR: 6.59; 95%CI: 2.39-18.17, <0.001), CKD stage 3 (aOR: 2.50; 95%CI: 1.36-4.59, =0.003), stage 4 (aOR: 5.47; 95%CI: 2.18-13.69, <0.001) or stage 5 (aOR: 1.71; 95%CI: 1.04-2.81, =0.036), and having chronic lung disease (aOR: 3.08; 95%CI: 1.22-7.77, =0.017) significantly increased the risk of COVID-19 mortality. In contrast, COVID-19 vaccination reduced the risk of COVID-19-associated death. This study highlights that more severe comorbidities, advanced age, and incomplete vaccination were associated with COVID-19 mortality.

摘要

众多研究表明,合并症是2019冠状病毒病(COVID-19)死亡的风险因素,但很少有研究考虑这些合并症的严重程度或阶段。本研究的目的是确定合并症的严重程度、年龄和COVID-19疫苗接种次数与COVID-19死亡率之间的关联。这项病例对照研究于2021年7月至2022年12月在印度尼西亚泗水的苏托莫博士综合学术医院进行。患者被分为未存活患者(病例组)和存活患者(对照组)。病例的纳入标准是基于鼻咽拭子逆转录聚合酶链反应(RT-PCR)检测确诊为COVID-19的成年住院患者。采用全样本抽样,纳入了1046例确诊的COVID-19患者,其中450例(43%)未存活患者和596例(57%)存活患者。最常见的合并症是糖尿病(DM)(82.7%)、慢性肾脏病(CKD)(43%)、高血压(25.7%)和肥胖(23.6%)。我们的多变量分析表明,年龄较大(调整后比值比:1.03;95%置信区间:1.02-1.04,<0.001)、男性(调整后比值比:1.29;95%置信区间:1.11-2.00,=0.007)、首次入院时为重症COVID-19(调整后比值比:3.13;95%置信区间:2.08-4.73,<0.001)、患有肺炎(调整后比值比:1.99;95%置信区间:1.21-3.33,=0.005)、糖化血红蛋白(HbA1c)≥9%的糖尿病控制不佳(调整后比值比:2.90;95%置信区间:1.72-4.89,<0.001)、体重指数(BMI)≥30的重度肥胖(比值比:2.90;95%置信区间:1.72-4.89,<0.001)、2期(调整后比值比:1.99;95%置信区间:1.12-3.53,=0.019)或3期(调整后比值比:6.59;95%置信区间:2.39-18.17,<0.001)高血压、3期(调整后比值比:2.50;95%置信区间:1.36-4.59,=0.003)、4期(调整后比值比:5.47;95%置信区间:2.18-13.69,<0.001)或5期(调整后比值比:1.71;95%置信区间:1.04-2.81,=0.036)CKD以及患有慢性肺病(调整后比值比:3.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6244/11391969/383ccada696e/NarraJ-4-e949-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验